Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Improved in vitro potency of Clofazimine derivatives against Neisseria species

European Journal of Medicinal Chemistry Reports(2024)10.1016/j.ejmcr.2024.100147Source: DataRank Database

Improved in vitro potency of Clofazimine derivatives against Neisseria species is a research paper published in European Journal of Medicinal Chemistry Reports (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.00)OA: goldTopics (26)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Jessica M. Lawson-Rulli,Reilly M. Coates,Jennifer Heldring ORCID,Marvin J. Miller ORCID,Rui Liu ORCID

Live enrichment

PubMed:38962287 PMC:PMC11218832 OpenAlex:https://openalex.org/W4392888210

NIAID NIH HHS

Grant: R37 AI054193

NIAID NIH HHS

Grant: R01 AI054193

National Institutes of Health

Grant: 2R37AI054193-10A1

Design, Syntheses and Studies of Novel Antituberculosis Agents

National Institutes of Health

FWCI

0.00

Citation Percentile

0.0%

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.ejmcr.2024.100147

publisherhttps://doi.org/10.1016/j.ejmcr.2024.100147

publisherhttps://api.elsevier.com/content/article/PII:S2772417424000190?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2772417424000190?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38962287

Fields of Study

Mycobacterium research and diagnosisLeprosy Research and TreatmentAntibiotic Resistance in Bacteria0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

ClofazimineAntimycobacterialAntimicrobialIn vitroBiologyMicrobiologyBacteriaPotencyPharmacologyLeprosyMedicineImmunologyMycobacterium tuberculosisTuberculosisGeneticsRS1-441Other systems of medicinePharmacy and materia medicaRZ201-999Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being